CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer
Mikio Kawamura(Mie University), Masato Kusunoki(Mie University), Yasuhiro Inoue(Mie University), Junichiro Hiro(Fujita Health University), Yuji Toiyama(Mie University), Susumu Saigusa(Mie University), Kouji Tanaka(Mie University), Yoshinaga Okugawa(Mie University Hospital), Yasuhiko Mohri(Mie University), Keiichi Uchida(Mie University)
Cited by 136
Related Papers
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
|Gastroenterology|2015|814
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
|Annals of Surgical Oncology|2009|324
Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer
|Annals of Surgery|2019|298